Trials / Conditions / High Risk Acute Lymphoblastic Leukemia
High Risk Acute Lymphoblastic Leukemia
5 registered clinical trials studyying High Risk Acute Lymphoblastic Leukemia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HS NCT06839456 | Children's Hospital of Philadelphia | Phase 1 / Phase 2 |
| Not Yet Recruiting | Blinatumomab Maintenance After Allo-HSCT NCT06438796 | Ruijin Hospital | Phase 2 |
| Unknown | CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL). NCT06078306 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Terminated | HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL NCT05006040 | University of Colorado, Denver | EARLY_Phase 1 |
| Unknown | Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT NCT05066958 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 1 / Phase 2 |